Biopharma’s biggest 2025 deals were driven by China-sourced assets, surging interest in bispecific antibodies, and rapid growth in AI-enabled drug discovery — trends highlighted and quantified using DealForma data. Read it here
Biopharma’s biggest 2025 deals were driven by China-sourced assets, surging interest in bispecific antibodies, and rapid growth in AI-enabled drug discovery — trends highlighted and quantified using DealForma data. Read it here
DealForma is the biopharma deal database providing you comprehensive information and dedicated analyst support to help you be more confident using quality data in your business development research.
Database
Company
Comparisons
Website Design by Once Interactive
